Your browser doesn't support javascript.
loading
Efficacy and Safety of Atezolizumab and Bevacizumab in the Real-World Treatment of Advanced Hepatocellular Carcinoma: Experience from Four Tertiary Centers.
Himmelsbach, Vera; Pinter, Matthias; Scheiner, Bernhard; Venerito, Marino; Sinner, Friedrich; Zimpel, Carolin; Marquardt, Jens U; Trojan, Jörg; Waidmann, Oliver; Finkelmeier, Fabian.
Afiliación
  • Himmelsbach V; Department of Gastroenterology, Hepatology and Endocrinology, University Hospital Frankfurt, 60590 Frankfurt, Germany.
  • Pinter M; Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, 1090 Vienna, Austria.
  • Scheiner B; Liver Cancer (HCC) Study Group Vienna, Medical University of Vienna, 1090 Vienna, Austria.
  • Venerito M; Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, 1090 Vienna, Austria.
  • Sinner F; Liver Cancer (HCC) Study Group Vienna, Medical University of Vienna, 1090 Vienna, Austria.
  • Zimpel C; Department of Gastroenterology, Hepatology and Infectious Diseases, Otto-Von Guericke University Hospital, 39120 Magdeburg, Germany.
  • Marquardt JU; Department of Gastroenterology, Hepatology and Infectious Diseases, Otto-Von Guericke University Hospital, 39120 Magdeburg, Germany.
  • Trojan J; Department of Internal Medicine I, Johannes Gutenberg University, 55131 Mainz, Germany.
  • Waidmann O; Department of Medicine I, University Medical Centre Schleswig-Holstein, Campus Lübeck, 23538 Lübeck, Germany.
  • Finkelmeier F; Department of Internal Medicine I, Johannes Gutenberg University, 55131 Mainz, Germany.
Cancers (Basel) ; 14(7)2022 Mar 28.
Article en En | MEDLINE | ID: mdl-35406493

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Cancers (Basel) Año: 2022 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Suiza

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Cancers (Basel) Año: 2022 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Suiza